Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TSHZ3 antisense RNA 1 (TSHZ3-AS1) is a long non-coding RNA (lncRNA) transcribed from the TSHZ3 locus but in the antisense direction. It is cataloged in major human gene databases as an lncRNA with no currently established protein-coding potential or direct molecular function. There are currently no documented roles for TSHZ3-AS1 as a therapeutic target, biomarker, or drug-interacted molecule. The biological activity and disease relevance of TSHZ3-AS1 remain unelucidated in the literature and major biomedical resources, distinguishing it from the nearby protein-coding TSHZ3 gene[7][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TSHZ3 antisense RNA 1 (TSHZ3-AS1).